首页 西医服务(usWST)-基本信息

西医服务(usWST)-基本信息

日报更新时间:

周报更新时间:04-11 03:39

行情信息

今开价:296.52

最高价:298.65

成交量:334724.0

昨收价:296.52

最低价:295.16

最新价:296.94

行情图标
概要信息

中文名称:西医服务


英文名称:West Pharmaceutical


行业:医疗


简介:West Pharmaceutical Services, Inc.是一家用于注射用药物的包装和运输的部件与系统的制造商,也是制药、医疗和消费性用品行业运输系统部件的制造商


电话:1-610-5942900


最新量化综合结论
百科信息
  • 相关网站
  • 员工交易记录
  • 持股信息
  • 领导人信息

交易日期 交易人 职位 类型 交易份额 价格
2019-06-20 Birkett (Bernard John) Chief Financial Officer Sell 710 122.04
2019-05-06 Zenner (Patrick J.) Director Buy 1565 --
2019-05-06 Zenner (Patrick J.) Director Buy 494 --
2019-05-06 Pucci (Paolo) Director Buy 1565 --
2019-05-06 Michels (Douglas A) Director Buy 1565 --
2019-05-06 Lai-Goldman (Myla P) Director Buy 1565 --
2019-05-06 Keller (Deborah L) Director Buy 1565 --
2019-05-06 Johnson (Paula A) Director Buy 1565 --
2019-05-06 Hofmann (Thomas W) Director Buy 1565 --
2019-05-06 Buthman (Mark A) Director Buy 1565 --
2019-05-06 Feehery William F Director Buy 1565 --
2019-04-29 MALONE DANIEL Officer Buy 4458 21.34
2019-04-29 MALONE DANIEL Officer Sell 4458 123.03
2019-02-28 Abraham (Silji) Officer Buy 477 106.14
2019-02-28 Montecalvo (David A) Officer Buy 526 106.14
2019-02-28 Favorite (Annette F) Officer Buy 1332 106.14
2019-02-28 Birkett (Bernard John) Chief Financial Officer Buy 385 106.14
2019-02-28 Miller (George Lloyd) General Counsel Buy 2575 106.14
2019-02-25 Abraham (Silji) Officer Sell 473 103.77
2019-02-18 Montecalvo (David A) Officer Buy 716 102.51
2019-02-18 MALONE DANIEL Officer Buy 1281 102.51
2019-02-18 Lai (Quintin J. Ph.D.) Officer Buy 561 102.51
2019-02-18 Favorite (Annette F) Officer Buy 863 102.51
2019-02-18 Flynn (Karen A) Officer Buy 2099 102.51
2019-02-18 GREEN ERIC MARK Chief Executive Officer Buy 6034 102.51

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
J.P. Morgan Investment Management, Inc. 1045408 1.42% -10097 -0.96% 2019-07-31
Neuberger Berman Group LLC 2612559 3.56% -61715 -2.31% 2019-03-31
Franklin Advisory Services, LLC 3126700 4.24% -- -- 2019-07-31
BlackRock Fund Advisors 3742588 5.07% -244361 -6.13% 2019-07-31
Franklin Advisers, Inc. 4518744 6.15% -279260 -5.82% 2019-03-31
Franklin Resources Inc 4521070 6.15% -279060 -5.81% 2019-03-31
BlackRock Inc 7111791 9.68% 172298 2.48% 2019-03-31
Vanguard Group Inc 7349460 10.00% 47872 0.66% 2019-03-31
T. Rowe Price Associates, Inc. 8770106 11.93% -224857 -2.50% 2019-03-31
Neuberger Berman Investment Advisers LLC 2612559 3.56% -61715 -2.31% 2019-03-31
State Street Corporation 2289560 3.12% 155303 7.28% 2019-03-31
Vanguard Investments Australia Ltd 2044612 2.77% 11760 0.58% 2019-07-31
Goldman Sachs Group Inc 1078158 1.47% 155115 16.80% 2019-03-31
USS Investment Management Ltd 1087078 1.48% -- -- 2019-03-31
Artisan Partners Limited Partnership 1111465 1.51% 5052 0.46% 2019-03-31
WCM Investment Management 1122116 1.53% 13448 1.21% 2019-03-31
Capital Research and Management Company 1435928 1.95% 61 -- 2019-07-31
Capital Research Global Investors 1435867 1.95% 534749 59.34% 2019-03-31
BAMCO Inc 1597709 2.17% -39994 -2.44% 2019-03-31
AllianceBernstein L.P. 1645894 2.24% -470821 -22.24% 2019-03-31
Geode Capital Management, LLC 1486306 2.02% 816211 121.81% 2018-12-31
BlackRock Asset Management Canada Ltd 8758939 11.92% 1167 0.01% 2019-05-31
JPMorgan Chase & Co 1638954 2.22% -202576 -11.00% 2018-09-30
Federated Investors Inc 943093 1.28% -61423 -6.11% 2018-12-31
Bessemer Group Inc 958737 1.29% 7921 0.83% 2018-09-30
William Blair Investment Management, LLC 1434617 1.94% -194122 -11.92% 2018-09-30
Hermes Fund Managers (Singapore) Pte. Limited 968945 1.31% 44169 4.78% 2018-06-30
BlackRock Institutional Trust Company NA 2359690 3.19% -108440 -4.39% 2018-06-30
Neuberger Berman LLC 3171180 4.28% -239627 -7.03% 2018-03-31
Fisher Asset Management, LLC 975204 1.32% -9047 -0.92% 2018-06-30
Fidelity Management & Research Company 1013064 1.37% 261375 34.77% 2018-10-31
Franklin Advisers Inc 4709484 6.40% 813898 20.89% 2018-06-30
AllianceBernstein LP 2678628 3.64% 20829 0.78% 2018-06-30
State Street Corp 2353270 3.20% -46001 -1.92% 2018-06-30
J.P. Morgan Investment Management Inc 1711438 2.33% 4297 0.25% 2018-06-30
Schroder Investment Management North America Inc. 9287294 1.58% 8467524 1032.91% 2018-06-30
State Street Global Markets, LLC 849301 1.15% -7527 -0.88% 2018-07-31
HHG PLC 875723 1.19% 186752 27.11% 2018-06-30
Janus Capital Management LLC 798241 1.09% 178408 28.78% 2018-06-30
Select Equity Group LP 1895916 2.58% -497099 -20.77% 2018-03-31
1832 Asset Management L.P 802030 1.10% 88670 12.43% 2018-03-31
GW&K Investment Management, LLC 882796 1.19% -74645 -7.80% 2017-12-31
Lord, Abbett & Co LLC 951339 1.29% 151555 18.95% 2017-12-31
TCW Asset Management Co 715727 0.97% 400459 127.02% 2017-12-31
Royal Bank Of Canada 712851 0.96% -94345 -11.69% 2017-12-31
Eagle Asset Management, Inc. 709645 0.96% -181920 -20.40% 2017-12-31
Columbia Wanger Asset Management LLC 781437 1.07% -142935 -15.46% 2016-09-30
Kalmar Investments Inc 787505 1.08% -43355 -5.22% 2016-09-30
Goldman, Sachs & Co. 792971 1.08% 145496 22.47% 2016-09-30
The Vanguard Group,Inc. 5499584 3.00% 298517420 0.10% 1999-11-30
BlackRock,Inc. 6049645 3.00% 328374731 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Champlain Mid Cap Fund, LLC 585875 0.79% 10165 1.77% 2019-07-31
American Funds AMCAP Fund 1434000 1.94% -- -- 2019-06-30
T. Rowe Price Mid-Cap Growth Fund 1500000 2.03% -- -- 2019-06-30
Neuberger Berman Genesis Fund 1698454 2.30% -98250 -5.47% 2019-06-30
Vanguard Small Cap Index 1879766 2.55% -54946 -2.84% 2019-06-30
Vanguard Total Stock Market Index Fund 2027488 2.75% 11314 0.56% 2019-06-30
iShares Core S&P Mid-Cap ETF 2156502 2.92% 4160 0.19% 2019-07-30
T. Rowe Price New Horizons Fund 3100492 4.20% 100100 3.34% 2019-06-30
Franklin Rising Dividends Fund 3126700 4.24% -- -- 2019-06-30
Vanguard Small Cap Growth Index Fund 1076426 1.46% -24086 -2.19% 2019-06-30
Vanguard Extended Market Index Fund 1010986 1.37% -16102 -1.57% 2019-06-30
JPMorgan Small Cap Equity Fund 874915 1.19% -- -- 2019-06-30
SPDR 836777 1.13% -14780 -1.74% 2019-06-30
Janus Henderson Triton Fund 798241 1.08% -- -- 2019-06-30
T. Rowe Price Health Sciences Fund 684559 0.93% 5800 0.85% 2019-06-30
iShares S&P Mid-Cap 400 Growth ETF 634298 0.86% -- -- 2019-07-30
Baron Small-Cap Growth Strategy-UBS 620000 0.84% -5000 -0.80% 2019-06-30
Baron Growth Fund 620000 0.84% -5000 -0.80% 2019-06-30
Vanguard Dividend Appreciation Index Fd 609366 0.83% 5180 0.86% 2019-06-30
Baron Asset Fund 598404 0.81% -- -- 2019-06-30
Franklin Rising Dividends Fd 3126700 4.24% -- -- 2019-06-30
iShares S&P US Mid-Cap ETF (CAD-Hedged) 2161028 2.94% -- -- 2019-05-30
iShares S&P US Mid-Cap ETF 2161028 2.94% -- -- 2019-05-30
iShares Core S&P US Total Market ETF 2161028 2.94% -- -- 2019-05-30
iShares Core MSCI AllCntry Wld exCan ETF 2161868 2.94% -- -- 2019-05-22
Vanguard Small Cap Index Fund 1935378 2.63% 13612 0.71% 2019-04-30
Dynamic Global Dividend Fund 530000 0.72% -- -- 2018-11-30
ZI Franklin US Opportunities 525138 0.71% -- -- 2019-01-31
VA CollegeAmerica AMCAP Fd 900000 1.21% 900000 -- 2018-12-31
ILI Franklin US Opportunities EUR 525138 0.71% -- -- 2019-01-31
Franklin US Opportunities Fund 525138 0.71% -- -- 2019-01-31
Artisan Mid Cap Fund 510311 0.69% -22156 -4.16% 2018-12-31
Old Westbury Small & Mid Cap Strat Fd 500300 0.68% -- -- 2018-10-31
Franklin Growth Opportunities Fund 447854 0.60% -- -- 2018-11-30
T. Rowe Price Small-Cap Value Fund 443000 0.60% -91100 -17.06% 2018-09-30
Vanguard Extended Market Idx Inv 975054 1.33% 15400 1.60% 2018-07-31
Vanguard Small Cap Growth Index Inv 1055344 1.44% 14368 1.38% 2018-07-31
T. Rowe Price Mid-Cap Growth 1500000 2.04% -- -- 2018-06-30
Vanguard Total Stock Mkt Idx 1859087 2.53% 1840 0.10% 2018-07-31
Neuberger Berman Genesis Inv 2138169 2.91% -72415 -3.28% 2018-06-30
T. Rowe Price New Horizons 3302800 4.49% -8600 -0.26% 2018-06-30
Franklin Rising Dividends Fund A 3141600 4.27% -- -- 2018-07-31
JPMorgan Small Cap Equity A 962184 1.31% -180229 -15.78% 2018-07-31
T. Rowe Price Health Sciences 884259 1.20% -- -- 2018-06-30
Janus Triton D 798241 1.09% 178408 28.78% 2018-06-30
Baron Growth Retail 675000 0.92% -55000 -7.53% 2018-06-30
Vanguard Dividend Appreciation ETF 576192 0.78% 1193 0.21% 2018-07-31
Baron Asset Retail 605404 0.82% -- -- 2018-06-30
Artisan Mid Cap Investor 578001 0.79% -53127 -8.42% 2018-06-30
T. Rowe Price Small-Cap Value 534100 0.73% -68400 -11.35% 2018-06-30
Franklin Rising Dividends VIP 2 454318 0.62% -51500 -10.18% 2018-07-31
iShares S&P Mid-Cap 400 Growth 399937 0.55% 3955 1.00% 2018-09-12
American Century Heritage Inv 406864 0.55% -60219 -12.89% 2017-12-31
Lord Abbett Value Opportunities A 407115 0.55% -6700 -1.62% 2018-01-31
Eagle Small Cap Growth A 645527 0.88% -- -- 2016-12-31
Vanguard Explorer Inv 779025 1.06% -91105 -10.47% 2016-09-30
Champlain - Small Cap Equity Tr 856150 1.20% -73850 -7.90% 2015-06-30
iShares Russell 2000 (AU) 1139310 1.60% -1434 -0.10% 2015-11-19
iShares Core S&P Mid-Cap (AU) 1252686 1.80% 1690 0.10% 2015-11-19
Vanguard Explorer Fund 1610880 2.20% -255965 -13.70% 2015-09-30
Franklin Rising Dividends 3141600 4.40% -- -- 2015-09-30

Patrick J. Zenner Patrick J. Zenner is a businessperson who has been at the helm of 6 different companies. Currently, Mr. Zenner occupies the position of Non-Executive Chairman at West Pharmaceutical Services, Inc. and Chairman at ArQule, Inc. He is also on the board of Biotechnology Innovation Organization, Selecta Biosciences, Inc., Creighton University and HealthCare Institute of New Jersey and Chairman of Fairleigh Dickinson University. Patrick J. Zenner previously occupied the position of Chairman for EXACT Sciences Corp., President & Chief Executive Officer for Hoffmann-La Roche, Inc., President & Chief Executive Officer of Roche Holdings, Inc. and Vice President & General Manager at Roche Laboratories, Inc. Mr. Zenner received an MBA from Fairleigh Dickinson University and an undergraduate degree from Creighton University.
William J. Federici Mr. William J. Federici is an Independent Director at Zynerba Pharmaceuticals, Inc. and a Chief Financial Officer, Treasurer & Senior VP at West Pharmaceutical Services, Inc. He is on the Board of Directors at Zynerba Pharmaceuticals, Inc. Mr. Federici was previously employed as an Independent Director by NuPathe, Inc., a National Industry Director-Pharmaceuticals by KPMG LLP, an Audit Partner by Arthur Andersen LLP, and a Trustee by Cancer Care, Inc. He also served on the board at Synvista Therapeutics, Inc. He received his undergraduate degree from Rutgers State University of New Jersey, an undergraduate degree from Livingstone College and an MBA from Rutgers State University of New Jersey.
Douglas A. Michels Douglas A. Michels is on the board of West Pharmaceutical Services, Inc., Tyme Technologies, Inc., St. Luke's Hospital & Health Network, Inc. and Miller Keystone Blood Center. Mr. Michels previously held the position of President, Chief Executive Officer & Director at OraSure Technologies, Inc., President of Johnson & Johnson Health Care Systems, Inc., Regional Manager-Sales at Ortho Diagnostic Systems, Inc. and Group Vice President-Global Marketing at Ortho-Clinical Diagnostics, Inc. Mr. Michels received an undergraduate degree from the University of Illinois and an MBA from Rutgers State University of New Jersey.
Eric Mark Green Eric Mark Green occupies the position of President, Chief Executive Officer & Director at West Pharmaceutical Services, Inc. Mr. Green is also on the board of St. Louis Children's Hospital and World Trade Center St. Louis. In the past Mr. Green held the position of President-Research Business Unit & Executive VP at Sigma-Aldrich Corp. He received an MBA from Olin Business School and an undergraduate degree from Bethel University.
Donald A. McMillan Donald A. McMillan is Vice President-Enterprise Business Systems at West Pharmaceutical Services, Inc.
Paolo Pucci Currently, Paolo Pucci is Chief Executive Officer & Director at ArQule, Inc. Mr. Pucci is also on the board of West Pharmaceutical Services, Inc. In the past Mr. Pucci held the position of Senior VP-Global Specialty Medicine Business Unit at Bayer AG President-US Pharmaceutical Operations at Bayer Pharmaceuticals Corp. and Senior Vice President for Bayer Pharma AG (both are subsidiaries of Bayer AG) and Managing Director at Eli Lilly Sweden AB. He received an undergraduate degree from Universit�0�1�0�2 degli Studi di Napoli Federico II and an MBA from The University of Chicago Booth School of Business.
Chris Ryan Chris Ryan is Vice President & General Manager-Global Generics at West Pharmaceutical Services, Inc. In his past career Mr. Ryan held the position of Strategic Marketer -Industrial Product Division at W. L. Gore & Associates, Inc. and Senior Business Analyst-Strategy & Acquisition at Cargill, Inc.
Heino Lennartz Heino Lennartz is Vice President & General Manager-Global Pharma at West Pharmaceutical Services, Inc. In the past Mr. Lennartz was Vice President-Finance for AIXTRON SE and Director-Business Systems Europe at GDX Automotive, Inc.
George Lloyd Miller George Lloyd Miller holds the position of Secretary, Senior Vice President & General Counsel of West Pharmaceutical Services, Inc. Mr. Miller is also on the board of West Pharmaceutical Services Cornwall Ltd. and West Pharmaceutical Services Group Ltd. In the past he was Secretary, Senior Vice President & General Counsel of Sigma-Aldrich Corp., General Counsel at Novartis Corp. and General Counsel for Novartis Services, Inc. Mr. Miller received a graduate degree from Georgetown University Law Center, an MBA from Thunderbird School of Global Management and an undergraduate degree from the University of St. Thomas (Minnesota).
Daniel Malone Daniel Malone is Vice President & Controller at West Pharmaceutical Services, Inc. Mr. Malone is also on the board of W.P.S.F. Ltd.
William F. Feehery Presently, William F. Feehery is Chief Executive Officer & Director at Certara USA, Inc. and President & Director at MECS, Inc. Dr. Feehery is also on the board of West Pharmaceutical Services, Inc. and President-Industrial Biosciences Business at E.I. du Pont de Nemours & Co. In the past Dr. Feehery occupied the position of President & Business Director at DuPont Displays and Director-Global Business at Dupont Photovoltaic Solutions. Dr. Feehery received an MBA and a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Pennsylvania.
John H. Weiland John H. Weiland occupies the position of Director & Vice President at Liberator Medical Holdings, Inc., Director & Vice President at Liberator Medical Supply, Inc. and Director & Vice President at Rochester Medical Corp. Mr. Weiland is also on the board of 5 other companies. He previously occupied the position of Vice President-Eastern United States at Baxter International, Inc. and Principal at American Hospital Supply Corp. (a subsidiary of Baxter International, Inc.), President & Chief Executive Officer at Pharmacia AB, President & Chief Executive Officer at Alfa Wassermann, Inc., Vice Chairman, President & Chief Operating Officer at C.R. Bard, Inc. (New Jersey) and Senior Vice President-North America at DENTSPLY International, Inc. Mr. Weiland received an undergraduate degree from DeSales University and an MBA from New York University.
Thomas W. Hofmann Thomas W. Hofmann holds the position of Chief Financial Officer & Senior Vice President at Sunoco Chemicals, Inc. He is also on the board of 10 other companies. In the past Mr. Hofmann occupied the position of Chief Financial Officer & Senior Vice President for Sunoco, Inc. and Director at Northern Tier Energy LLC. Mr. Hofmann received an undergraduate degree from the University of Delaware and a graduate degree from Villanova University.
Myla P. Lai-Goldman Myla P. Lai-Goldman is an entrepreneur who founded Personalized Science LLC, GeneCentric Therapeutics, Inc. and CancerGuide Diagnostics, Inc. Currently, she is Executive Chairman at GeneCentric Therapeutics, Inc. She is also on the board of West Pharmaceutical Services, Inc., Council for Entrepreneurial Development and Qvella Corp. and Managing Partner at Personalized Science LLC. In her past career she held the position of Chief Executive & Scientific Officer at CancerGuide Diagnostics, Inc., Medical Director at Center for Molecular Biology & Pathology, Chief Medical Officer & Executive Vice President at Laboratory Corp. of America Holdings Principal at ViroMed Laboratories, Inc. and Principal at National Genetics Institute, Inc. (both are subsidiaries of Laboratory Corp. of America Holdings) and Chief Scientific Officer of Roche Biomedical Laboratories, Inc. Myla P. Lai-Goldman received a doctorate from Columbia University and an undergraduate degree from the University of Pennsylvania.
David A. Montecalvo David A. Montecalvo holds the position of SVP-Global Operations & Supply Chain at West Pharmaceutical Services, Inc. He previously was Vice President-Operations of Urologix, Inc. and Vice President-Contract Manufacturing Operations at Medtronic Plc. Mr. Montecalvo received an MBA from St. Thomas University (Florida) and an undergraduate degree from Case Western Reserve University.
Quintin John Lai Quintin John Lai is Vice President-Corporate Development & Strategy at West Pharmaceutical Services, Inc. He previously occupied the position of Senior Product Engineer at Arco Alaska, Inc., Managing Director at Robert W. Baird & Co., Inc., Managing Director at Robert W. Baird & Co., Inc. (Broker) and Vice President-Investor Relations and Strategy at Sigma-Aldrich Corp. Quintin John Lai received an undergraduate degree from The University of Alabama, a doctorate from the University of Wisconsin and an MBA from The University of Chicago Booth School of Business.
Mark A. Buthman Currently, Mark A. Buthman occupies the position of Chief Financial Officer & Director at I-Flow Corp. He is also on the board of IDEX Corp., West Pharmaceutical Services, Inc. and Pavillon International. In his past career Mr. Buthman was Executive Vice President of Kimberly-Clark Corp. Mark A. Buthman received an undergraduate degree from the University of Iowa.
Paula A. Johnson Paula A. Johnson is on the board of Eaton Vance Corp., West Pharmaceutical Services, Inc. and The Isabella Stewart Gardner Museum, Inc. and President at Wellesley College, Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Associate Professor at Harvard Medical School, Member of National Academy of Medicine of United States and Executive Director-Connors Center at The Brigham & Women's Hospital, Inc. In the past Dr. Johnson held the position of Professor at Harvard T.H. Chan School of Public Health. She received a doctorate from Harvard Medical School, a graduate degree from Harvard T.H. Chan School of Public Health and an undergraduate degree from Radcliffe College.
Karen A. Flynn Karen A. Flynn is on the board of Chester County Economic Development Council and Recro Pharma, Inc. and Member of Healthcare Businesswomens Association, Member of The Forum of Executive Women and Chief Commercial Officer & Senior Vice President at West Pharmaceutical Services, Inc. In her past career Ms. Flynn was Principal at New York Life Insurance Co., Principal at Och-Ziff Capital Management Group LLC, Principal at The Bank of New York Co., Inc., Vice President-Global Accounts at Catalent Pharma Solutions, Inc. and Controller of MDeverywhere, Inc. Karen A. Flynn received an undergraduate degree from the University of Notre Dame, a graduate degree from Boston University and a graduate degree from the University of Pennsylvania.
Silji Abraham Silji Abraham is Senior VP, Chief Digital & Transformation Officer at West Pharmaceutical Services, Inc. In his past career Mr. Abraham held the position of Chief Information Officer & Vice President of Sigma-Aldrich Corp. and Chief Information Officer & EVP at EMD Millipore Corp. Mr. Abraham received an MBA from Lawrence Technological University and an undergraduate degree from Madurai Kamaraj University.
Deborah L. V. Keller Deborah L. V. Keller is on the board of West Pharmaceutical Services, Inc. and Wisconsin Alumni Research Foundation and Member of Society of Toxicology and Member of American Association of Pharmaceutical Scientists. In her past career Ms. Keller was Executive VP & CEO-Covance Drug Development at Laboratory Corp. of America Holdings, Chief Executive Officer at Covance, Inc., Vice President-Analytical Services at Covance Laboratories Ltd. and Manager-Quality Assurance at Hazleton Laboratories Corp. Deborah L. V. Keller received an undergraduate degree and an MBA from the University of Wisconsin.
Annette F. Favorite Presently, Annette F. Favorite holds the position of Chief Human Resources Officer & Senior VP at West Pharmaceutical Services, Inc. In the past Ms. Favorite was Vice President-Global Talent Management at International Business Machines Corp. Ms. Favorite received a graduate degree from the University of South Carolina and a graduate degree from the University of Georgia.
Bernard J. Birkett Currently, Bernard J. Birkett is Chief Financial Officer, Treasurer & Senior VP for West Pharmaceutical Services, Inc. In the past Mr. Birkett held the position of Chief Financial Officer & Treasurer at Merit Medical Systems, Inc. He received an undergraduate degree from National University of Ireland and a graduate degree from University College Dublin.
Quintin John Lai Quintin John Lai is Vice President-Corporate Development & Strategy at West Pharmaceutical Services, Inc. He previously occupied the position of Senior Product Engineer at Arco Alaska, Inc., Managing Director at Robert W. Baird & Co., Inc., Managing Director at Robert W. Baird & Co., Inc. (Broker) and Vice President-Investor Relations and Strategy at Sigma-Aldrich Corp. Quintin John Lai received an undergraduate degree from The University of Alabama, a doctorate from the University of Wisconsin and an MBA from The University of Chicago Booth School of Business.
Quintin John Lai Quintin John Lai is Vice President-Corporate Development & Strategy at West Pharmaceutical Services, Inc. He previously occupied the position of Senior Product Engineer at Arco Alaska, Inc., Managing Director at Robert W. Baird & Co., Inc., Managing Director at Robert W. Baird & Co., Inc. (Broker) and Vice President-Investor Relations and Strategy at Sigma-Aldrich Corp. Quintin John Lai received an undergraduate degree from The University of Alabama, a doctorate from the University of Wisconsin and an MBA from The University of Chicago Booth School of Business.
Eric Resnick Presently, Eric Resnick is Chief Technology Officer & Vice President at West Pharmaceutical Services, Inc. He is also on the board of NanoPass Technologies Ltd. He received an undergraduate degree from the University of Massachusetts Lowell and an MBA from the University of Phoenix.
Graham S Reynolds Graham S Reynolds is Vice President & General Manager-Global Biologics at West Pharmaceutical Services, Inc.
Graham S Reynolds Graham S Reynolds is Vice President & General Manager-Global Biologics at West Pharmaceutical Services, Inc.
Mike Schaefers Mr. Mike Schaefers is Vice President-Product Management at West Pharmaceutical Services, Inc.
Erin O'Brien Currently, Erin O'Brien occupies the position of Senior Director-Marketing at West Pharmaceutical Services, Inc. Ms. O'Brien is also on the board of Canine Partners for Life. Ms. O'Brien received an undergraduate degree from The Pennsylvania State University.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐